LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea
LivaNova presented new data from the OSPREY study showing that its PolySync programming algorithm increased the cumulative AHI response rate to 84.5% for OSA patients treated with pHGNS, up from a 65% baseline response rate. The substudy demonstrated that reprogramming non-responders with simultaneous-contact stimulation converted the majority into responders, with PolySync slated for integration into commercial products.
Key figures
- Prior responder rate
- 65%
- Pma supplement timeline
- H2 2026
- Cumulative response rate
- 84.5%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.